4//SEC Filing
HOLMLUND JON T 4
Accession 0000899243-20-014428
CIK 0001563577other
Filed
May 27, 8:00 PM ET
Accepted
May 28, 4:50 PM ET
Size
8.7 KB
Accession
0000899243-20-014428
Insider Transaction Report
Form 4
HOLMLUND JON T
Chief Medical Officer
Transactions
- Sale
Common Stock
2020-05-26$12.00/sh−692$8,304→ 0 total - Exercise/Conversion
Stock Option
2020-05-26−692→ 5,004 totalExercise: $1.07Exp: 2023-01-26→ Common Stock (692 underlying) - Exercise/Conversion
Common Stock
2020-05-26$1.07/sh+692$740→ 692 total
Footnotes (2)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2019.
- [F2]The option has fully vested and is currently exercisable.
Documents
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001227367
Filing Metadata
- Form type
- 4
- Filed
- May 27, 8:00 PM ET
- Accepted
- May 28, 4:50 PM ET
- Size
- 8.7 KB